cbdMD (YCBD) Debt Ratio (2016 - 2024)

cbdMD (YCBD) posted Debt Ratio of 0.03 for Q4 2024, down 84.94% sequentially from 0.21 in Q3 2024.

cbdMD (YCBD) Debt Ratio (2016 - 2024) Analysis & Trends

cbdMD has reported Debt Ratio for 9 years, with the latest figure at 0.03 in Q4 2024.

Quarterly Debt Ratio changed N/A year-over-year to 0.03 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.03 (changed N/A YoY) and the FY2024 annual result came in at 0.21, up 37484674.97% from the prior year.
Debt Ratio slipped to 0.03 in Q4 2024 per YCBD's latest filing, from 0.21 in the prior quarter.
Over five years, Debt Ratio peaked at 0.21 in Q3 2024 and troughed at 0.0 in Q3 2023.
A 5-year average of 0.03 and a median of 0.0 in 2022 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2023 and 2024: Debt Ratio slumped 99.98% in 2023, then surged 37484674.97% in 2024.
Over 5 years, Debt Ratio stood at 0.01 in 2020, then slumped by 91.98% to 0.0 in 2021, then surged by 226.85% to 0.0 in 2022, then plunged by 99.98% to 0.0 in 2023, then surged by 5643574.6% to 0.03 in 2024.
According to Business Quant data, Debt Ratio over the past three periods registered 0.03, 0.21, and 0.08 for Q4 2024, Q3 2024, and Q2 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-	-0.13
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn	0.42
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn	0.60
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	0.32
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn	-
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn	0.38
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn	-
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn	0.29
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	0.12
10	cbdMD	5.41 Mn	3.29 Mn	3.04 Mn	-

Download Data